All Type of News
Dream Pharma in deal with Laboratoires SMB
Dream Pharma has entered into an exclusive licensing agreement with Begiumbased Laboratoires SMB S.A., for its asthma product 'BUSAL', said a company spokesperson on October 31.
The inhaler contains a mixture of a ...
Yuyu to introduce herbal medicinal product
Yuyu Pharm said on October 30 that it has signed a licensing agreement with Swiss-based Zeller AG to distribute Vitex agnus castus fruit (VAC) extract (code name: ZE-440) for the treatment of premenstrual syndrome (PM...
SK Chemicals launches Korea’s 13th new drug
SK Chemicals announced on November 1 its release of M-vix (mirodenafil), a homegrown impotence treatment. Its initial target is to record 10 billion won in sales next year.
Demonstrating the strength of the country...
Domestic drug makers skimping on R&D investment
Despite their relatively large assets, the nation’s 34 Korean pharmaceutical companies spend considerably less on research and development (R&D) than promotional expenses, industry data showed recently.
According t...
Drug makers feel relieved over stronger Korean won
Korean pharmaceutical firms are breathing a sign of relief as the Korean won remains strong against major currencies, in the midst of external negative factors – government’s relented price cut and rebate scandal.
...
10 pharmaceutical firms fined W20 bil. won
10 drug makers have been fined around 20 billion won for unfair business practices, the country’s antitrust regulator said on November 1. Industry sources expected some of them would face more than 10 billion won in f...
Corporate watchdog sues 5 drug makers
The Fair Trade Commission (FTC) said on November 1 that it plans to refer five out of the 10 companies that profiteered the most from the unfair trading, soon to prosecutors.
Those companies involved are Dong-A Pha...
Government-private meeting discusses launching period of generic products
The government plans to set up a system, through a revision of the Korean Pharmaceutical Affairs Law, to suspend the approval process of a generic drug after screening the results of its bioequivalence testing related...
Delay of generics' license will hurt pharmaceutical sector
The government's plan to deny a local pharmaceutical company the license to sell generic drugs for at least two years under the proposed revision of the Pharmaceutical Affairs Law stirred heated debate in a government...
Dong-A Shareholders vote against Kang-Korea Alcohol's 5 nominees
Shareholders of Dong-A Pharmaceutical voted against all of five Kang-Korea Alcohol director nominees at the October 31 EGM - Jee Yong-seok Jee, Park Sun-keun, Jung Eun-sup, Lee Jun-haeng and Park Jeong-sam, a company ...
